|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Ma J, Goding Sauer A, Newman
LA and Jemal A: Breast cancer statistics, 2017, racial disparity in
mortality by state. CA Cancer J Clin. 67:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reed E and Corner J: Defining the illness
trajectory of metastatic breast cancer. BMJ Support Palliat Care.
5:358–365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Redig AJ and McAllister SS: Breast cancer
as a systemic disease: A view of metastasis. J Intern Med.
274:113–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McShane LM, Altman DG, Sauerbrei W, Taube
SE, Gion M and Clark GM; Statistics Subcommittee of the NCI-EORTC
Working Group on Cancer Diagnostics, : REporting recommendations
for tumour MARKer prognostic studies (REMARK). Br J Cancer.
93:387–391. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Costa-Pinheiro P, Montezuma D, Henrique R
and Jerónimo C: Diagnostic and prognostic epigenetic biomarkers in
cancer. Epigenomics. 7:1003–1015. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dworkin AM, Huang TH and Toland AE:
Epigenetic alterations in the breast: Implications for breast
cancer detection, prognosis and treatment. Semin Cancer Biol.
19:165–171. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karsli-Ceppioglu S, Dagdemir A, Judes G,
Ngollo M, Penault-Llorca F, Pajon A, Bignon YJ and Bernard-Gallon
D: Epigenetic mechanisms of breast cancer: An update of the current
knowledge. Epigenomics. 6:651–664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang HD, Kim PJ, Eun JW, Shen Q, Kim HS,
Shin WC, Ahn YM, Park WS, Lee JY and Nam SW: Oncogenic potential of
histone-variant H2A.Z.1 and its regulatory role in cell cycle and
epithelial-mesenchymal transition in liver cancer. Oncotarget.
7:11412–11423. 2016.PubMed/NCBI
|
|
10
|
Rangasamy D: Histone variant H2A.Z can
serve as a new target for breast cancer therapy. Curr Med Chem.
17:3155–3161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen H, Lorton B, Gupta V and Shechter D:
A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through
histone H3 and H4 arginine methylation coupled transcriptional
activation and repression. Oncogene. 36:373–386. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yokoyama Y, Matsumoto A, Hieda M, Shinchi
Y, Ogihara E, Hamada M, Nishioka Y, Kimura H, Yoshidome K,
Tsujimoto M, et al: Loss of histone H4K20 trimethylation predicts
poor prognosis in breast cancer and is associated with invasive
activity. Breast Cancer Res. 16:R662014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Tian R, Gao H, Yang Y, Williams BRG,
Gantier MP, McMillan NAJ, Xu D, Hu Y and Gao Y: Identification of a
histone family gene signature for predicting the prognosis of
cervical cancer patients. Sci Rep. 7:164952017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The Cancer Genome Atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
15
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al The Gene Ontology Consortium, : Gene ontology: Tool for the
unification of biology. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gene Ontology Consortium, . Gene Ontology
Consortium: Going forward. Nucleic Acids Res. 43:D1049–D1056. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Van Parys T, Melckenbeeck I, Houbraken M,
Audenaert P, Colle D, Pickavet M, Demeester P and Van de Peer Y: A
Cytoscape app for motif enumeration with ISMAGS. Bioinformatics.
33:461–463. 2017.PubMed/NCBI
|
|
23
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pontén F, Jirström K and Uhlen M: The
Human Protein Atlas - a tool for pathology. J Pathol. 216:387–393.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mizuno H, Kitada K, Nakai K and Sarai A:
PrognoScan: A new database for meta-analysis of the prognostic
value of genes. BMC Med Genomics. 2:182009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang R, Liang L, Luo D, Feng Z, Huang Q,
He R, Gan T, Yang L and Chen G: Downregulation of miR-30a is
associated with poor prognosis in lung cancer. Med Sci Monit.
21:2514–2520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abbasi S, Rasouli M, Nouri M and Kalbasi
S: Association of estrogen receptor-α A908G (K303R) mutation with
breast cancer risk. Int J Clin Exp Med. 6:39–49. 2013.PubMed/NCBI
|
|
28
|
Basse C and Arock M: The increasing roles
of epigenetics in breast cancer: Implications for pathogenicity,
biomarkers, prevention and treatment. Int J Cancer. 137:2785–2794.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katz TA, Huang Y, Davidson NE and
Jankowitz RC: Epigenetic reprogramming in breast cancer: From new
targets to new therapies. Ann Med. 46:397–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fidalgo F, Rodrigues TC, Silva AG, Facure
L, de Sá BC, Duprat JP, Achatz MI, Rosenberg C, Carraro DM and
Krepischi AC: Role of rare germline copy number variation in
melanoma-prone patients. Future Oncol. 12:1345–1357. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ohshima K, Hatakeyama K, Nagashima T,
Watanabe Y, Kanto K, Doi Y, Ide T, Shimoda Y, Tanabe T, Ohnami S,
et al: Integrated analysis of gene expression and copy number
identified potential cancer driver genes with
amplification-dependent overexpression in 1,454 solid tumors. Sci
Rep. 7:6412017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mirisola V, Mora R, Esposito AI, Guastini
L, Tabacchiera F, Paleari L, Amaro A, Angelini G, Dellepiane M,
Pfeffer U, et al: A prognostic multigene classifier for squamous
cell carcinomas of the larynx. Cancer Lett. 307:37–46. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Castel D, Philippe C, Calmon R, Le Dret L,
Truffaux N, Boddaert N, Pagès M, Taylor KR, Saulnier P, Lacroix L,
et al: Histone H3F3A and HIST1H3B K27M mutations define two
subgroups of diffuse intrinsic pontine gliomas with different
prognosis and phenotypes. Acta Neuropathol. 130:815–827. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Braunstein M, Liao L, Lyttle N, Lobo N,
Taylor KJ, Krzyzanowski PM, Kalatskaya I, Yao CQ, Stein LD, Boutros
PC, et al: Downregulation of histone H2A and H2B pathways is
associated with anthracycline sensitivity in breast cancer. Breast
Cancer Res. 18:162016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen X, Hu H, He L, Yu X, Liu X, Zhong R
and Shu M: A novel subtype classification and risk of breast cancer
by histone modification profiling. Breast Cancer Res Treat.
157:267–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hedrich CM: Epigenetics in SLE. Curr
Rheumatol Rep. 19:582017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu N, Qiu X, Luo Y, Yuan J, Li Y, Lei W,
Zhang G, Zhou Y, Su Y and Lu Q: Abnormal histone modification
patterns in lupus CD4+ T cells. J Rheumatol. 35:804–810.
2008.PubMed/NCBI
|
|
38
|
Alam S, Arif Z and Alam K: Glycated-H2A
histone is better bound by serum anti-DNA autoantibodies in SLE
patients: Glycated-histones as likely trigger for SLE?
Autoimmunity. 48:19–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bernatsky S, Ramsey-Goldman R, Labrecque
J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB,
Gladman D, et al: Cancer risk in systemic lupus: An updated
international multi-centre cohort study. J Autoimmun. 42:130–135.
2013. View Article : Google Scholar : PubMed/NCBI
|
